Effectiveness of fixed-dose combination of paritaprevir, ritonavir, ombitasvir, and dasabuvir in patients with chronic hepatitis C virus infection and chronic kidney diseases: Real-life experiences
European Journal of Gastroenterology & Hepatology | Mar 10, 2019
Most read this week